chr2-239895291-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 0P and 15B. BP4_StrongBP6_ModerateBP7BS1BS2
The ENST00000419408.5(NDUFA10):āc.318A>Gā(p.Arg106=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00145 in 468,808 control chromosomes in the GnomAD database, including 9 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ).
Frequency
Genomes: š 0.00037 ( 2 hom., cov: 32)
Exomes š: 0.0020 ( 7 hom. )
Consequence
NDUFA10
ENST00000419408.5 synonymous
ENST00000419408.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.111
Genes affected
NDUFA10 (HGNC:7684): (NADH:ubiquinone oxidoreductase subunit A10) The protein encoded by this gene is a component of 42 kDa complex I, the first enzyme complex in the electron transport chain of mitochondria. This protein has NADH dehydrogenase activity and oxidoreductase activity. It transfers electrons from NADH to the respiratory chain. A mutation in this gene was found in an individual with Leigh syndrome. [provided by RefSeq, Apr 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -15 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.98).
BP6
Variant 2-239895291-T-C is Benign according to our data. Variant chr2-239895291-T-C is described in ClinVar as [Benign]. Clinvar id is 2652082.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-0.111 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.000368 (56/152282) while in subpopulation SAS AF= 0.0116 (56/4820). AF 95% confidence interval is 0.00919. There are 2 homozygotes in gnomad4. There are 42 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 2 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NDUFA10 | NR_136158.2 | n.4373A>G | non_coding_transcript_exon_variant | 10/11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NDUFA10 | ENST00000419408.5 | c.318A>G | p.Arg106= | synonymous_variant | 5/6 | 5 | |||
NDUFA10 | ENST00000677057.1 | n.4428A>G | non_coding_transcript_exon_variant | 10/11 | |||||
NDUFA10 | ENST00000679183.1 | c.*244A>G | 3_prime_UTR_variant, NMD_transcript_variant | 12/13 |
Frequencies
GnomAD3 genomes AF: 0.000368 AC: 56AN: 152164Hom.: 2 Cov.: 32
GnomAD3 genomes
AF:
AC:
56
AN:
152164
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00153 AC: 225AN: 146866Hom.: 3 AF XY: 0.00208 AC XY: 165AN XY: 79158
GnomAD3 exomes
AF:
AC:
225
AN:
146866
Hom.:
AF XY:
AC XY:
165
AN XY:
79158
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00197 AC: 622AN: 316526Hom.: 7 Cov.: 0 AF XY: 0.00272 AC XY: 487AN XY: 178984
GnomAD4 exome
AF:
AC:
622
AN:
316526
Hom.:
Cov.:
0
AF XY:
AC XY:
487
AN XY:
178984
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000368 AC: 56AN: 152282Hom.: 2 Cov.: 32 AF XY: 0.000564 AC XY: 42AN XY: 74454
GnomAD4 genome
AF:
AC:
56
AN:
152282
Hom.:
Cov.:
32
AF XY:
AC XY:
42
AN XY:
74454
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
15
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Oct 01, 2022 | NDUFA10: BS1, BS2 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at